UMC’s board members

UMC’s board consists of six members and their alternates, appointed by WHO and by the Swedish government.

The operations of UMC as a WHO Collaborating Centre are governed by an agreement between WHO Headquarters and the Swedish government. The centre has an international board – WHO and the Swedish government each appoint three members and alternate members.

Since May 2019, the board has been chaired by Dr Filippa Nyberg, Chief Medical Officer, Karolinska University Hospital, and Associate Professor, Karolinska Institutet.

The members of the board are listed below.


Appointed by the Swedish government
 

  • Dr Filippa Nyberg,
    Chief Medical Officer, Karolinska University Hospital, and Associate Professor, Karolinska Institutet.
  • Professor Johanna Adami,
    Principal, Sophiahemmet University
  • Dr Thomas Bradley,
    Pharmacovigilance consultant, Stockholm

Alternates

  • Professor Gert Ragnarsson,
    Professor and Scientific Advisor
  • Dr Karin Meyer,
    CEO, Swedish Pharmaceutical Society
  • One vacancy


Appointed by WHO

  • Dr Rogério Gaspar
    Director, Regulation and Prequalification, World Health Organization
  • Dr Fred Moin Siyoi,
    CEO, Pharmacy and Poisons Board, Kenya
  • One vacancy

Alternates

  • Dr Shanthi Pal,
    Acting Team Lead, Pharmacovigilance, World Health Organization
  • Dr Jun Kitahara,
    Director, International Information Group, Risk Communication Promotion Division, Safety, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Dr Juan Roldán Saelzer,
    Head of Pharmacovigilance Subdepartment of the Department National Medicines Agency at the Institute of Public Health of Chile
Last modified on: December 3, 2021